USPTO serial 78502794
Serial No. 78502794
Reviewed by CopyMark Law Group
Reg. 3152858Status 710
- Filing date
- Status date
- Registration date
- Oct 10, 2006
- Examiner
- TIERNEY, MARGERY
- Law office
- —
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 78502794?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific or medical research use; diagnostic preparations or reagents for scientific or research use, biochemical reagents for scientific or medical research use; biochemical diagnostic preparations or reagents for scientific or research use | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment[ and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances,] nervous diseases, [diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents;] medical and clinical diagnostic reagents for clinical or medical laboratory use | SECTION 8 - CANCELLED | — |
| 010 | [Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting medical diagnostic tests and blood specimen analysis of the human blood clotting system; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis, hemofiltration] | SECTION 8 - CANCELLED | — |
| 035 | [Computerized database management, namely, processing data for third parties] | SECTION 8 - CANCELLED | — |
| 041 | [Educational services, namely, providing seminars, informational events and/or workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gendiagnostics] | SECTION 8 - CANCELLED | — |
| 042 | [Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; licensing of intellectual property; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, providing pharmaceutical advice to others regarding governmental regulatory laws and practices, performing pre-clinical studies, quality control; ]preparation of expert opinions in the field of[ chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry], product research and development of medical devices and pharmaceutical preparations, [and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries;] performance of pre-clinical studies, namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products[; bio-chemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment;] scientific research on and development of[ medical diagnostic equipment and] pharmaceutical preparations and products for the treatment of[ tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances,] nervous diseases, [diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases,] pain [and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Paion GmbH
- Other trademarks owned by PAION DEUTSHLAND GMBH
- Other trademarks owned by PAION DEUTSHLAND GMBH
- Other trademarks owned by PAION DEUTSHLAND GMBH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 12, 2017 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Oct 10, 2015 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| May 20, 2013 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| May 20, 2013 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Apr 18, 2013 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 4, 2013 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Apr 4, 2013 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 10, 2006 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 18, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 28, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| May 25, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 19, 2006 | ALIE | ASSIGNED TO LIE | — |
| May 4, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 4, 2006 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 4, 2006 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 4, 2006 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 20, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 23, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2006 | PAPER RECEIVED | — | |
| Feb 14, 2006 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 10, 2005 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 10, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 4, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 27, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 27, 2005 | PAPER RECEIVED | — | |
| May 24, 2005 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 24, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 24, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 28, 2004 | NWAP | NEW APPLICATION ENTERED | — |